DeFronzo on a novel renal-hepatic axis in endogenous glucose production, arguments for and against the current model of glucose regulation of β-cell KATP channels from Rutter and Sweet (for) and Merrins and Kibbey (against), and more!
Description
Welcome to the June 2024 episode of DiabetesBio—the American Diabetes Association's podcast for its flagship research publication, Diabetes. In this episode of DiabetesBio, Drs. Kirk Habegger, Darleen Sandoval, and Kevin Williams discuss the latest and greatest content in the June 2024 issue of Diabetes.
2:27 : Darleen and Kirk are joined by Dr. Ralph A. DeFronzo, senior author of the article "Effect of Dapagliflozin on Renal and Hepatic Glucose Kinetics in T2D and NGT Subjects." This article is freely accessible at https://doi.org/10.2337/db23-0457.
20:26 : In this month's Sweet Talk segment, Kevin and Kirk highlight this month's Point-Counterpoint feature on whether a new model is needed on the regulation of β-cell KATP channels in glucose metabolism. First, they talk to Drs. Matthew J. Merrins and Richard G. Kibbey, authors of the Counterpoint, titled "Glucose Regulation of β-Cell KATP Channels: It Is Time for a New Model!" This article is freely accessible at https://doi.org/10.2337/dbi23-0032.
35:00 : Kevin next is joined by Drs. Guy A. Rutter and Ian R. Sweet, authors of the Point article, titled "Glucose Regulation of β-Cell KATP Channels: Is a New Model Needed?" This article is freely accessible at https://doi.org/10.2337/dbi23-0031.
To learn more about Diabetes and DiabetesBio, please visit diabetesjournals.org/diabetes. Thank you for listening, and don't forget to smash that "follow" button!
United States
